Richard K. Prins - May 12, 2023 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Stock symbol
AMPH
Transactions as of
May 12, 2023
Transactions value $
-$260,925
Form type
4
Date filed
5/16/2023, 07:59 PM
Previous filing
Jun 27, 2023
Next filing
Jun 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $83.5K +5K +10.56% $16.69 52.3K May 12, 2023 Direct
transaction AMPH Common Stock Sale -$210K -5K -9.55% $42.06 47.3K May 12, 2023 Direct F1
transaction AMPH Common Stock Gift $0 -3K -6.34% $0.00 44.3K May 12, 2023 Direct
transaction AMPH Common Stock Options Exercise $83.5K +5K +11.28% $16.69 49.3K May 15, 2023 Direct
transaction AMPH Common Stock Sale -$218K -5K -10.13% $43.50 44.3K May 15, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock option (right to buy) Options Exercise $0 -5K -99.77% $0.00 11.7 May 12, 2023 Common Stock 5K $16.69 Direct F3
transaction AMPH Stock option (right to buy) Options Exercise $0 -5K -42.81% $0.00 6.68K May 15, 2023 Common Stock 5K $16.69 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.98 to $42.14, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.50 to $43.52, inclusive.
F3 Shares subject to the option are fully vested and immediately exercisable.